| Drug | Class | Adult | Paediatric | Notes |
|---|---|---|---|---|
| Vitamin A[1] | Fat-soluble vitamin | Not applicable — paediatric guideline | 9 months: 100,000 IU PO once. 1–5 years: 200,000 IU PO every 6 months. Acute SAM or measles: 200,000 IU PO × 3 doses (day 1, 2, 14) | Universal supplementation in high-deficiency settings (UIP); also given with measles vaccine; contraindicated in pregnancy |
| Iron-folic acid (paediatric formulation)[1] | Iron + B-vitamin combination | Not applicable — paediatric guideline | Anaemia Mukt Bharat: 8–10 mg elemental iron + 100 µg folic acid syrup biweekly 6–59 months; tablet weekly 5–10 years; treatment dose for IDA 3–6 mg/kg/day | Programme supplementation reduces IDA prevalence; treat IDA with elemental iron 3–6 mg/kg/day for 3 months |
| Albendazole (deworming)[1] | Anthelminthic (benzimidazole) | Not applicable — paediatric guideline | ≥12 months: 400 mg PO single dose every 6 months | National Deworming Day biannual programme 1–19 years; reduces helminth burden, anaemia, and malnutrition |
| F-75 / F-100 therapeutic milk (SAM inpatient)[1] | Therapeutic feed | Not applicable — paediatric guideline | F-75 stabilisation 130 mL/kg/day; transition to F-100 at rehabilitation 150–200 mL/kg/day | Inpatient management of SAM at NRC/MTC per WHO 10-step protocol; outpatient via RUTF for uncomplicated SAM |
Breastfeeding, complementary feeding, supplementation, and screening for under- and over-nutrition in children aged 0–10 years.